MENU
SEPN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Septerna (SEPN) Ownership - Who owns Septerna?

Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform... Show more

Profile

Industry
N/A
Address
250 East Grand Avenue
Phone
+1 650 338-3533
Employees
130
Web
https://www.septerna.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.93B
P/E Ratio
-78.08
Total Cash
372.32M
Projected Growth
N/A
Total Debt
22.55M
Revenue
98.88M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
7.98
Total Debt/Equity
N/A
Revenue/Share
2.21 USD as % of share price
Who owns Septerna? SEPN symbol Ownership - Tickeron.com